Stevens–Johnson syndrome and toxic epidermal necrolysis: The Food and Drug Administration adverse event reporting system, 2004–2013

• Junko Abe,
• Kanako Mataki,
• Ryogo Umetsu,
• Natsumi Ueda,
• Yamato Kato,
• Yoko Nakayama,
• Yasutomi Kinosada,
• Hideaki Hara,
• Naoki Inagaki,
• Mitsuhiro Nakamura

Affiliations

Junko Abe

Drug Informatics, Gifu Pharmaceutical University, Gifu, Japan

Kanako Mataki

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan

Ryogo Umetsu

Drug Informatics, Gifu Pharmaceutical University, Gifu, Japan

Natsumi Ueda

Drug Informatics, Gifu Pharmaceutical University, Gifu, Japan

Yamato Kato

Drug Informatics, Gifu Pharmaceutical University, Gifu, Japan

Yoko Nakayama

Drug Informatics, Gifu Pharmaceutical University, Gifu, Japan

Yasutomi Kinosada

United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu, Japan

Hideaki Hara

Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan

Naoki Inagaki

Department of Pharmacology, Gifu Pharmaceutical University, Gifu, Japan

Mitsuhiro Nakamura

Drug Informatics, Gifu Pharmaceutical University, Gifu, Japan